Since LOX is able to effectively deplete lactate in cell cultures and inhibit cancer cell growth [6,10], we recently examined the effect of systemic LOX injection (via tail vein) on mouse mammary tumor and circulating lactate levels. The gene discussed is LOX; the disease is cancer.